Chemomab Therapeutics Ltd. (Nasdaq: CMMB), (Chemomab), a clinical-stage biotechnology company focused on the discovery and development of innovative therapeutics for fibrotic and inflammatory diseases with high unmet need, today announced that the company will participate in a number of investor and scientific conferences in June 2022. JMP Securities Life Sciences Conference: Date: Thursday, June 16, 2022  Venue: Lotte Palace Hotel, New York, NY USA Format: In-person live and webcast presentation; One-on-one meetings on June 16 Time: 11:00...